OGN NYSE Week ended 31 Jul 2026

Weekly Investor Report

Organon & Co · Healthcare · Drug Manufacturers - General

Open interactive chart View report data
Latest close 13.55 USD
0.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 29.1% above the Trend Line and sits at 99.4% of its 52-week range. The latest completed week returned 0.2%, after a 0.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is bearish with 31/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal; earnings are due in 2d.

Setup score 65 out of 100
Latest Close 13.55 USD 31 Jul 2026
1W Return 0.2% latest completed week
4W Return 0.0% short-term follow-through
12W Return 1.7% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.2% Latest completed week; four-week move 0.0%. Indicator stack 60/59 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 31/100 conviction; expected move 5.1%. News sentiment 56/100 64 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 29.1% above the Trend Line and sits at 99.4% of its 52-week range. The latest completed week returned 0.2%, after a 0.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9412-week average 0.82

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.94Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.0% over four weeks, 1.7% over 12 weeks, and 40.2% over one year. The current trend has remained active for 14 consecutive weeks.

Performance by holding period

1W0.2%
4W0.0%
12W1.7%
26W59.3%
52W40.2%
Active trend streak14 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.64Latest activity-pressure read.
Pressure change-35.7%Four-week change in activity pressure.
Leadership29.77Latest relative-leadership reading.
RS change-6.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength95/100Blend of value, momentum, and quality. Underlying universe rank 6; rank 1 is best.
Value87/100Relative valuation strength. Underlying universe rank 14; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum79/100Medium-term price momentum. Underlying universe rank 22; rank 1 is best.
Growth1/100Revenue and earnings growth. Underlying universe rank 100; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework85/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
14.4x
Price divided by trailing earnings.
Price / sales
0.6x
Market value relative to trailing revenue.
EV / EBITDA
8.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
53.1%
Gross profit retained from each unit of revenue.
Operating margin
16.7%
Operating profit retained from revenue.
Free-cash-flow margin
17.6%
Free cash flow generated from revenue.
Return on invested capital
5.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-2.1%
Latest one-year revenue growth.
EPS growth
-67.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-14.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.6%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

OGN shows bearish options pressure with a 31/100 conviction score, put-call volume ratio of 1.67, expected move of 5.1%, and Sharemaestro trend signal active.

Conviction31/100
Expected move5.1%
Put/call volume1.67
Pressure-25
Speculation0
Volatility35
Trend agreement66
Open options detail
Insider activity11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 64 relevant articles.

23 positive · 37 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move5.1%Nearest-chain priced movement where available.
52-week drawdown-0.4%Distance below the 52-week high.
13-week volatility0.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2610 weeks finished lower.
Best week+38.8%Week of 10 Apr.
Worst week-10.0%Week of 6 Mar.
Latest week+0.2%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks2
Modest losses6
Sharp losses4
Recent vol0.3%13-week weekly-return volatility.
Base vol9.3%52-week weekly-return volatility.
Up/down split27/23Count of positive and negative weeks in the 52-week window.
Average skew6.8% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape67/100

Trend, activity pressure, participation, and risk combine to a 67/100 tape read.

 Indicator analysis91/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.94; No reversal markers Factors84/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 66; Small Cap Core rank 23 SVQF85/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 150.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options53/100

OGN shows bearish options pressure with a 31/100 conviction score, put-call volume ratio of 1.67, expected move of 5.1%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 5.1% Sentiment56/100

Weighted news tone is neutral across 64 relevant articles.

Vanguard Portfolio Management (OGN) discloses 15.2M-share, 5.77% Organon & Co stake Insiders11 / 9

11 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202613.55 USD0.2%10.50 USD13.41 USD0.6429.7712.1MOn
24 Jul 202613.52 USD0.0%10.29 USD13.44 USD0.7831.3416.2MOn
17 Jul 202613.52 USD0.0%10.07 USD13.48 USD0.8830.9810.3MOn
10 Jul 202613.52 USD-0.2%9.85 USD13.51 USD0.9529.5115.4MOn
3 Jul 202613.55 USD0.4%9.64 USD13.54 USD0.9931.927.4MOn
26 Jun 202613.50 USD0.5%9.42 USD13.57 USD1.0234.7011.0MOn
19 Jun 202613.43 USD-0.1%9.23 USD13.60 USD1.0531.2712.6MOn
12 Jun 202613.44 USD0.6%9.02 USD13.63 USD1.0732.8812.2MOn
5 Jun 202613.36 USD0.1%8.82 USD13.66 USD1.0933.0712.2MOn
29 May 202613.34 USD-0.7%8.60 USD13.69 USD1.1129.9414.8MOn
22 May 202613.43 USD0.2%8.38 USD13.71 USD1.2033.0814.8MOn
15 May 202613.40 USD0.5%8.23 USD13.74 USD1.2934.5222.8MOn
8 May 202613.33 USD0.5%8.10 USD13.77 USD1.3234.6536.8MOn
1 May 202613.27 USD18.0%7.97 USD13.80 USD1.2937.72212.7MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.